scholarly journals E-033 Procedural outcome depending arterial diameter in the acute M2 occlusive ischemic stroke patients treated with endovascular thrombectomy

2021 ◽  
Author(s):  
J Kim ◽  
K Lee ◽  
J Kang ◽  
B Kim ◽  
M Han ◽  
...  
Keyword(s):  
Ischemic Stroke ◽  
Stroke Patients ◽  
Arterial Diameter ◽  
Endovascular Thrombectomy ◽  
Procedural Outcome

scholarly journals Low-Dose Tirofiban Improves Functional Outcome in Acute Ischemic Stroke Patients Treated With Endovascular Thrombectomy

Stroke ◽  
2017 ◽  
Vol 48 (12) ◽  
pp. 3289-3294 ◽  
Author(s):  
Wenbo Zhao ◽  
Ruiwen Che ◽  
Shuyi Shang ◽  
Chuanjie Wu ◽  
Chuanhui Li ◽  
...  
Keyword(s):  
Ischemic Stroke ◽  
Acute Ischemic Stroke ◽  
Functional Outcome ◽  
Low Dose ◽  
Stroke Patients ◽  
Endovascular Thrombectomy

scholarly journals Early NT-ProBNP (N-Terminal Probrain Natriuretic Peptide) Elevation Predicts Malignant Edema and Death After Reperfusion Therapy in Acute Ischemic Stroke Patients

Stroke ◽  
2021 ◽  
Author(s):  
Xuting Zhang ◽  
Shenqiang Yan ◽  
Wansi Zhong ◽  
Yannan Yu ◽  
Min Lou
Keyword(s):  
Ischemic Stroke ◽  
Acute Ischemic Stroke ◽  
Natriuretic Peptide ◽  
Odds Ratio ◽  
Intravenous Thrombolysis ◽  
Reperfusion Therapy ◽  
Stroke Patients ◽  
Endovascular Thrombectomy ◽  
Median Serum ◽  
The Relationship

Background and Purpose: We aimed to investigate the relationship between early NT-proBNP (N-terminal probrain natriuretic peptide) and all-cause death in patients receiving reperfusion therapy, including intravenous thrombolysis and endovascular thrombectomy (EVT). Methods: This study included 1039 acute ischemic stroke patients with early NT-proBNP data at 2 hours after the beginning of alteplase infusion for those with intravenous thrombolysis only or immediately at the end of EVT for those with EVT. We performed natural log transformation for NT-proBNP (Ln(NT-proBNP)). Malignant brain edema was ascertained by using the SITS-MOST (Safe Implementation of Thrombolysis in Stroke-Monitoring Study) criteria. Results: Median serum NT-proBNP level was 349 pg/mL (interquartile range, 89–1250 pg/mL). One hundred twenty-one (11.6%) patients died. Malignant edema was observed in 78 (7.5%) patients. Ln(NT-proBNP) was independently associated with 3-month mortality in patients with intravenous thrombolysis only (odds ratio, 1.465 [95% CI, 1.169–1.836]; P =0.001) and in those receiving EVT (odds ratio, 1.563 [95% CI, 1.139–2.145]; P =0.006). The elevation of Ln(NT-proBNP) was also independently associated with malignant edema in patients with intravenous thrombolysis only (odds ratio, 1.334 [95% CI, 1.020–1.745]; P =0.036), and in those with EVT (odds ratio, 1.455 [95% CI, 1.057–2.003]; P =0.022). Conclusions: An early increase in NT-proBNP levels was related to malignant edema and stroke mortality after reperfusion therapy.

Telemedicine for Evaluation of Stroke Patients

2018 ◽  
pp. 118-127
Author(s):  
Kaustubh Limaye ◽  
Lawrence R. Wechsler
Keyword(s):  
Ischemic Stroke ◽  
Intracerebral Hemorrhage ◽  
Video Communication ◽  
Legal Issues ◽  
Comprehensive Care ◽  
Stroke Patients ◽  
Endovascular Thrombectomy ◽  
Intravenous Alteplase

Telemedicine uses video communication to evaluate patients at an originating site by a distant physician. Telestroke was developed to apply telemedicine for the delivery of stroke expertise to hospitals with limited or no available stroke capability. This chapter reviews the most commonly used models of telestroke networks. It discusses the evidence for telestroke, including its value in managing patients with ischemic stroke who are candidates for intravenous alteplase and endovascular thrombectomy, as well as patients with intracerebral hemorrhage. Economic, legislative, and legal issues of treating patients within a telestroke network are also reviewed. Future advances in telemedicine will continue to deliver expert care in a way that brings comprehensive care to patient’s doorstep.

scholarly journals Serum Albumin Levels and Clinical Outcomes Among Ischemic Stroke Patients Treated with Endovascular Thrombectomy

2021 ◽  
Vol Volume 17 ◽  
pp. 401-411
Author(s):  
Jie Gao ◽  
Ying Zhao ◽  
Mingyang Du ◽  
Hongquan Guo ◽  
Ting Wan ◽  
...  
Keyword(s):  
Ischemic Stroke ◽  
Serum Albumin ◽  
Clinical Outcomes ◽  
Stroke Patients ◽  
Endovascular Thrombectomy

scholarly journals Endovascular Treatment for Acute Stroke in Cerebral Amyloid Angiopathy

Stroke ◽  
2021 ◽  
Vol 52 (10) ◽  
Author(s):  
Johannes M. Weller ◽  
Simon Jonas Enkirch ◽  
Christopher Bogs ◽  
Tim Bastian Braemswig ◽  
Milani Deb-Chatterji ◽  
...  
Keyword(s):  
Ischemic Stroke ◽  
Endovascular Treatment ◽  
Acute Ischemic Stroke ◽  
Functional Outcome ◽  
Odds Ratio ◽  
Adjusted Odds Ratio ◽  
Amyloid Angiopathy ◽  
Stroke Patients ◽  
Endovascular Thrombectomy ◽  
Cerebral Amyloid

Background and Purpose: We aimed to compare outcome of endovascular thrombectomy in acute ischemic stroke in patients with and without cerebral amyloid angiopathy (CAA). Methods: We included patients with and without possible or probable CAA based on the modified Boston criteria from an observational multicenter cohort of patients with acute ischemic stroke and endovascular thrombectomy, the German Stroke Registry Endovascular Treatment trial. We analyzed baseline characteristics, procedural parameters, and functional outcome after 90 days. Results: Twenty-eight (17.3%) of 162 acute ischemic stroke patients were diagnosed with CAA based on iron-sensitive magnetic resonance imaging performed before endovascular thrombectomy. CAA patients were less likely to have a good 90-day outcome (14.3 versus 37.8%). National Institutes of Health Stroke Scale score (adjusted odds ratio, 0.88; P <0.001), successful recanalization (adjusted odds ratio 6.82; P =0.005), and CAA (adjusted odds ratio 0.28; P =0.049) were independent outcome predictors. Intravenous thrombolysis was associated with an increased rate of good outcome (36.3% versus 0%, P =0.031) in CAA. Conclusions: Endovascular thrombectomy with or without thrombolysis appears beneficial in acute ischemic stroke patients with possible or probable CAA, but is associated with a worse functional outcome. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT03356392.

Sign in / Sign up

Export Citation Format

Share Document